Discover how 68Ga/177Lu-PSMA I&T is transforming prostate cancer treatment through theranostics, combining precise diagnosis with targeted therapy.
Discover how [(18)F]YC-88, a revolutionary PSMA-targeting radiotracer, provides unprecedented clarity in prostate cancer detection with rapid clearance from healthy tissues.
Discover how 99mTc-labelled low molecular weight inhibitors are transforming prostate cancer detection through precise PSMA targeting and SPECT imaging.